Your shopping cart is currently empty

CZL80 is a brain-penetrant caspase-1 inhibitor with an IC50 of 0.01 μM that is used to study febrile seizures and subsequent epileptogenic susceptibility. CZL80 reduces neuronal excitability, decreases the incidence of febrile seizure generation at 7.5 mg/kg intravenously, and mitigates long-term neurological dysfunction following photothrombosis, establishing CZL80 as a valuable tool for neuroinflammation, seizure biology, and stroke-induced pathology.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $35 | - | In Stock | |
| 5 mg | $56 | - | In Stock | |
| 10 mg | $91 | - | In Stock | |
| 25 mg | $183 | - | In Stock | |
| 50 mg | $297 | - | In Stock | |
| 100 mg | $475 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $62 | - | In Stock |
| Description | CZL80 is a brain-penetrant caspase-1 inhibitor with an IC50 of 0.01 μM that is used to study febrile seizures and subsequent epileptogenic susceptibility. CZL80 reduces neuronal excitability, decreases the incidence of febrile seizure generation at 7.5 mg/kg intravenously, and mitigates long-term neurological dysfunction following photothrombosis, establishing CZL80 as a valuable tool for neuroinflammation, seizure biology, and stroke-induced pathology. |
| Targets&IC50 | Caspase-1:0.01 μM |
| In vivo | CZL80 (10, 30 mg/kg/day, intraperitoneal injection, for 7 days) ameliorated motor dysfunction in C57BL/6 mice and Caspase-1⁻/⁻ mice after photothrombotic stroke [2]. CZL80 (0.0075, 0.075, 0.75, and 7.5 mg/kg, intravenous injection, administered every other day) reduced epileptic seizure incidence in a dose-dependent manner, prolonged epileptic seizure latency, and increased the induction threshold of high-grade fever febrile convulsions in Casp1⁻/⁻ mice [1]. |
| Synonyms | CZL-80, CZL 80 |
| Molecular Weight | 366.39 |
| Formula | C19H14N2O4S |
| Cas No. | 313482-91-6 |
| Smiles | O=C(O)C=1C=CC=C(C1)NC(=O)C=2C=CC=C(C2)NC(=O)C=3SC=CC3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO: ≥ 160 mg/mL, Sonication is recommended. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.